News
-
-
-
-
-
PRESS RELEASE
Teva becomes strategic commercialization partner for Formycon’s biosimilar candidate FYB203 (Eylea®/ aflibercept) in major parts of Europe and Israel
Teva partners with Formycon for commercialization of biosimilar FYB203 (Eylea®) in Europe and Israel, aiming to expand access to innovative medicines -
REGULATED PRESS RELEASE
bioMérieux strengthens its point of care presence with the acquisition of the immunoassay start-up SpinChip
bioMérieux strengthens its point of care presence with the acquisition of the immunoassay start-up SpinChip. The innovative diagnostics platform aims to revolutionize MI diagnosis and improve patient outcomes -
PRESS RELEASE
Critical infrastructure protection with automated people screening from dormakaba and Rohde & Schwarz
dormakaba and Rohde & Schwarz partner to offer innovative APS solution for critical infrastructure protection, increasing security and efficiency. Global pilot projects underway in the USA, Singapore, and the Netherlands -
-
-
